.Pharmacolibrary.Drugs.C_CardiovascularSystem.C07A_BetaBlockingAgents.C07AA03_Pindolol.Pindolol

Information

Pindolol is a non-selective beta-adrenergic blocker used primarily to treat hypertension and occasionally angina pectoris. It is an approved drug and has been widely used in clinical practice.

Pharmacokinetics

Pharmacokinetic parameters reported for healthy adult volunteers, primarily males and females, after a single oral dose.

References

1. Salako, LA, et al., & Falase, AO (1979). Pharmacokinetics of pindolol in Africans. Experientia 35(2) 250–251. DOI:10.1007/BF01920646 PUBMED:https://pubmed.ncbi.nlm.nih.gov/421850

2. Gonçalves, PVB, et al., & Lanchote, VL (2020). A Pilot Study of the Maternal-Fetal Pharmacokinetics of Furosemide in Plasma, Urine, and Amniotic Fluid of Hypertensive Parturient Women Under Cesarean Section. Journal of clinical pharmacology 60(12) 1655–1661. DOI:10.1002/jcph.1681 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32562572

3. Juma, FD (1983). Pharmacokinetics of pindolol in Kenyan Africans. European journal of clinical pharmacology 25(3) 425–426. DOI:10.1007/BF01037959 PUBMED:https://pubmed.ncbi.nlm.nih.gov/6628532

Revisions

• 06/2025 initial generated model